These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21386868)

  • 1. Neuromuscular disease: acute treatment for myasthenia gravis.
    Gilhus NE
    Nat Rev Neurol; 2011 Mar; 7(3):132-4. PubMed ID: 21386868
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immune globulin in myasthenia gravis.
    Gajdos P
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
    Jensen P; Bril V
    J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma treatment in diseases of the neuromuscular junction.
    Cornelio F; Antozzi C; Confalonieri P; Baggi F; Mantegazza R
    Ann N Y Acad Sci; 1998 May; 841():803-10. PubMed ID: 9668333
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic plasma exchange in a patient of myasthenic crisis, refractory to intravenous immunoglobulin and immunosuppressive therapy.
    Prakash S; Hans R; Sharma RR; Lal V; Marwaha N
    Neurol India; 2017; 65(6):1409-1412. PubMed ID: 29133726
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose intravenous immunoglobulin in transient neonatal myasthenia gravis.
    Bassan H; Muhlbaur B; Tomer A; Spirer Z
    Pediatr Neurol; 1998 Feb; 18(2):181-3. PubMed ID: 9535308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.
    Dhawan PS; Goodman BP; Harper CM; Bosch PE; Hoffman-Snyder CR; Wellik KE; Wingerchuk DM; Demaerschalk BM
    Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin for myasthenia gravis.
    Gajdos P; Chevret S; Toyka K
    Cochrane Database Syst Rev; 2003; (2):CD002277. PubMed ID: 12804431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin for myasthenia gravis.
    Gajdos P; Chevret S; Toyka KV
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD002277. PubMed ID: 23235588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin for myasthenia gravis.
    Gajdos P; Chevret S; Toyka K
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002277. PubMed ID: 16625559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin for myasthenia gravis.
    Gajdos P; Chevret S; Toyka K
    Cochrane Database Syst Rev; 2008 Jan; (1):CD002277. PubMed ID: 18254004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma exchange and intravenous immunoglobulin in autoimmune myasthenia gravis.
    Gajdos P; Chevret S; Clair B; Tranchant C; Chastang C
    Ann N Y Acad Sci; 1998 May; 841():720-6. PubMed ID: 9668320
    [No Abstract]   [Full Text] [Related]  

  • 13. [Respective indications of plasma exchange and high-dose immunoglobulins in polyradiculoneuritis and myasthenia gravis].
    Raphaël JC; Annane D; Chevret S; Chillet P; Gajdos P
    Presse Med; 1996 Oct; 25(31):1516-22. PubMed ID: 8958883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-minimization analysis comparing intravenous immunoglobulin with plasma exchange in the management of patients with myasthenia gravis.
    Furlan JC; Barth D; Barnett C; Bril V
    Muscle Nerve; 2016 Jun; 53(6):872-6. PubMed ID: 26521889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis.
    Guptill JT; Juel VC; Massey JM; Anderson AC; Chopra M; Yi JS; Esfandiari E; Buchanan T; Smith B; Atherfold P; Jones E; Howard JF
    Autoimmunity; 2016 Nov; 49(7):472-479. PubMed ID: 27684107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patients.
    Alipour-Faz A; Shojaei M; Peyvandi H; Ramzi D; Oroei M; Ghadiri F; Peyvandi M
    Acta Neurol Belg; 2017 Mar; 117(1):245-249. PubMed ID: 27530310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myasthenia gravis].
    Tanaka K
    Nihon Rinsho; 2004 May; 62 Suppl 5():580-5. PubMed ID: 15197988
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study.
    Heatwole C; Johnson N; Holloway R; Noyes K
    J Clin Neuromuscul Dis; 2011 Dec; 13(2):85-94. PubMed ID: 22361692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
    Guptill JT; Sanders DB; Evoli A
    Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of IVIg and PLEX in patients with myasthenia gravis.
    Barth D; Nabavi Nouri M; Ng E; Nwe P; Bril V
    Neurology; 2011 Jun; 76(23):2017-23. PubMed ID: 21562253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.